MANGALAM vs VINEETLAB: Stock Comparison

MANGALAM DRUG & CHEM vs VINEET LABORATORIESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

VINEET LABORATORIES is the larger company by market capitalisation. MANGALAM DRUG & CHEM shows a higher ROE, lower leverage and a higher net margin, while VINEET LABORATORIES shows faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MANGALAM leads 3; VINEETLAB leads 6 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MANGALAMVINEETLAB

Valuation lens

What price are you paying?

Market CapContext only
₹48 Cr
₹73 Cr
EPSVINEETLAB has the higher reading
₹-4.83
₹0.84
Book ValueContext only
₹65.11
₹23.74
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VINEETLAB is the larger company
₹73 Cr vs ₹48 Cr
EPS
VINEETLAB has higher earnings per share
₹0.84 vs ₹-4.83
Revenue Growth (TTM YoY)
VINEETLAB has faster revenue growth
11.05% vs -7.5%
Qtr Sales Growth
VINEETLAB has stronger quarterly sales growth
214.43% vs 0%
Qtr Profit Growth
VINEETLAB has stronger quarterly profit growth
31.66% vs -1.13%
ROE
MANGALAM has a higher ROE
-42.41% vs -69.22%
ROCE
VINEETLAB has a higher ROCE
-11.29% vs -15.52%
Net Margin
MANGALAM has a higher net margin
-19.13% vs -26.92%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMANGALAMVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMANGALAMVINEETLAB
Live Price₹30.02₹37.37
Day Change-0.92%-0.35%
Volume18,72638,381
52-Week High₹79.7₹49.99
52-Week Low₹22.8₹27.96
Distance from 52W High-62.33%-25.25%

Valuation

MetricMANGALAMVINEETLAB
Market Cap₹48 Cr₹73 Cr
EPS₹-4.83₹0.84
Book Value₹65.11₹23.74
Dividend Yield0%0%

Growth

MetricMANGALAMVINEETLAB
Revenue Growth (TTM YoY)-7.5%11.05%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%214.43%
Qtr Profit Growth-1.13%31.66%

Profitability & Leverage

MetricMANGALAMVINEETLAB
ROE-42.41%-69.22%
ROCE-15.52%-11.29%
Net Margin-19.13%-26.92%
Operating Margin-13.66%-11.25%
Debt to Equity0.99x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMANGALAMVINEETLAB
Promoter Holding35.65%5.98%
FII Holding0.11% 0.21 pp0.5% 0.14 pp
DII Holding0%
Public Holding64.24% 0.22 pp93.52% 0.14 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MANGALAM DRUG & CHEM and VINEET LABORATORIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.